PAW
WST icon

Plan A Wealth’s West Pharmaceutical WST Stock Holding History

Plan A Wealth’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
+871
New +$266K 0.13% 122

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Plan A Wealth's WST Position: Q2 2026 in Review

Plan A Wealth opened a new position in West Pharmaceutical (WST) in Q2 2026: 871 shares worth $313K. The stake represents 0.13% of the portfolio and ranks #122 among its holdings.

571 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Plan A Wealth held 871 shares of West Pharmaceutical worth $313K as of Q2 2026.
  • West Pharmaceutical was a new Plan A Wealth position in Q2 2026.
  • West Pharmaceutical made up 0.13% of Plan A Wealth's portfolio in Q2 2026, its #122 holding.
  • 571 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Plan A Wealth's 13F filing for Q2 2026, filed 14 Jul 2026.